Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.

Nonalcoholic fatty liver disease is a global public health issue that affects 25% to 30% of adults globally, and the prevalence is showing an increasing trend. 1 Nonalcoholic fatty liver disease not only increases the risk of cirrhosis and hepatocellular carcinoma but is also a risk factor for the incidence of extrahepatic diseases such as diabetes, extrahepatic malignancies, and cardiovascular disease. 2 At diagnosis, nonalcoholic fatty liver di

also in 63,971 other papers